Effects of a pain consult and patient education and monitoring: a prospective study in oncology patients
ISRCTN | ISRCTN68236655 |
---|---|
DOI | https://doi.org/10.1186/ISRCTN68236655 |
Secondary identifying numbers | NTR613; EMC 2005 - 257 |
- Submission date
- 28/04/2006
- Registration date
- 28/04/2006
- Last edited
- 10/08/2009
- Recruitment status
- No longer recruiting
- Overall study status
- Completed
- Condition category
- Signs and Symptoms
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data
Record updated in last year
Plain English summary of protocol
Not provided at time of registration
Contact information
Dr W.H. Oldenmenger
Scientific
Scientific
Erasmus Medical Center
Daniel den Hoed Cancer Center
P.O. Box 5201
Rotterdam
3008 AE
Netherlands
Phone | +31 (0)10 4391439 |
---|---|
w.h.oldenmenger@erasmusmc.nl |
Study information
Study design | Randomised controlled trial |
---|---|
Primary study design | Interventional |
Secondary study design | Randomised controlled trial |
Study setting(s) | Not specified |
Study type | Treatment |
Scientific title | |
Study objectives | It is hypothesised that a pain consult at the specialized pain clinic in combination with Patient Education Program is more effective in reducing average pain intensity compared to a pain consult alone. A pain consult at the specialized pain clinic is more effective in reducing average pain intensity compared to standard care. |
Ethics approval(s) | Ethics approval received from the local medical ethics committee |
Health condition(s) or problem(s) studied | Cancer pain |
Intervention | 1. Standard care 2. Second opinion pain consult at the specialist pain clinic 3. Second opinion pain consult combined with Pain Education Program and monitoring by nurse specialists |
Intervention type | Other |
Primary outcome measure | Average pain reduction measured by numeric rating scale during the study period. |
Secondary outcome measures | Effect of the interventions after 2, 4 and 8 weeks on: 1. Adherence to ATC analgesics 2. Worst pain reduction 3. Average pain reduction 4. Present pain reduction 5. Proportion of patients with clinically relevant pain reduction 6. Pain interference 7. Quality of life 8. Reduction of side effects 9. Adequacy of pain treatment 10. Pain knowledge |
Overall study start date | 01/02/2006 |
Completion date | 31/12/2007 |
Eligibility
Participant type(s) | Patient |
---|---|
Age group | Adult |
Sex | Both |
Target number of participants | 165 |
Key inclusion criteria | 1. Cancer-related pain or cancer treatment related pain for at least two weeks 2. Nociceptive pain 3. Average pain intensity score of 4 or more 4. Accessibility by telephone 5. A life expectancy of at least three months 6. Informed consent |
Key exclusion criteria | 1. Neuropathic pain 2. Residing in nursing home or retirement home 3. Pain not treated with oral medication 4. Radiotherapy in the past two weeks |
Date of first enrolment | 01/02/2006 |
Date of final enrolment | 31/12/2007 |
Locations
Countries of recruitment
- Netherlands
Study participating centre
Erasmus Medical Center
Rotterdam
3008 AE
Netherlands
3008 AE
Netherlands
Sponsor information
Erasmus Medical Center (Netherlands)
University/education
University/education
P.O. Box 2040
Rotterdam
3000 CA
Netherlands
https://ror.org/018906e22 |
Funders
Funder type
University/education
Erasmus Medical Center (Netherlands)
Government organisation / Universities (academic only)
Government organisation / Universities (academic only)
- Alternative name(s)
- Erasmus Medical Center, Erasmus MC, Erasmus Universitair Medisch Centrum, Erasmus University Medical Center, Universitair Medisch Centrum Rotterdam, Erasmus Universitair Medisch Centrum Rotterdam, EMC
- Location
- Netherlands
Results and Publications
Intention to publish date | |
---|---|
Individual participant data (IPD) Intention to share | No |
IPD sharing plan summary | Not provided at time of registration |
Publication and dissemination plan | Not provided at time of registration |
IPD sharing plan |